Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DO0C7S
|
|||
| Drug Name |
ASP2074
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Aggressive cancer [ICD-11: 2A00-2F9Z; ICD-10: R45.6; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Astelllas
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05646797) A Phase 1/1b Study of ASP2074 in Participants With Metastatic or Locally Advanced Solid Tumors. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.